Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Filing Date
February 9, 2023
Document Date
February 9, 2023
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.